TTPH Tetraphase Pharmaceuticals Inc.

$2.12 -3.64%

1,908,900 Shares Traded
1,100,175 Average Volume (last 30 days)

as of February 16, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $218.99 thousand
If Intiated on the First, Shorts Have Realized a Year to Date Return of:67.23%
If Intiated One Month Ago, Shorts Have Realized a Return of:66.13%
If Initiated Five Days ago, Shorts Have Realized a Return of:61.17%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Bearish

Short Stats

Short Percent to Float 5.36%
Short Interest2.74 million
Float51.03 million
Short Ratio6.98
Market Cap$113.11 million
Market Maker ActivityDaily Short Volume


Biotech Forum Daily Digest For February 15th (SeekingAlpha)
Your Daily Pharma Scoop: Achaogen Update, Catabasis' Positive Results, Bristol-Myers Squibb/Nektar Collaboration (SeekingAlpha)
Midday Gainers / Losers (2/14/2018) (SeekingAlpha)
INVESTOR ALERT: Investigation of Tetraphase Pharmaceuticals Announced by Holzer & Holzer (Business Wire)
Healthcare - Top 5 Gainers / Losers as of 11:00 am (2/14/2018) (SeekingAlpha)
Premarket Losers as of 9:05 am (2/14/2018) (SeekingAlpha)
Premarket analyst action - healthcare (SeekingAlpha)
U.S. Biotech/Pharma Sector Daily Observations Letter: February 13, 2018 (Featuring Tetraphase Pharmaceuticals) (SeekingAlpha)
Tetraphase Failures - Look Beyond The Panic (SeekingAlpha)
After Hours Gainers / Losers (2/13/2018) (SeekingAlpha)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 57.3%

Earnings Stats

PE Ratio -0.74
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $6.64
50 Day Moving Average $5.91
52 Week High $9.93
52 Week Low $2.1

Data provided for free by IEX. Questions? Read the FAQ